HomeTNXP • NASDAQ
add
Tonix Pharmaceuticals Holding Corp
Previous close
$0.16
Day range
$0.15 - $0.16
Year range
$0.12 - $3.31
Market cap
13.27M USD
Avg Volume
3.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.78M | — |
Operating expense | 28.74M | -12.18% |
Net income | -27.32M | 13.76% |
Net profit margin | -723.00 | — |
Earnings per share | -1.82 | 48.00% |
EBITDA | -26.07M | 18.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 24.95M | -79.25% |
Total assets | 154.46M | -31.56% |
Total liabilities | 48.93M | 164.38% |
Total equity | 105.52M | — |
Shares outstanding | 84.49M | — |
Price to book | 0.09 | — |
Return on assets | -46.52% | — |
Return on capital | -57.58% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -27.32M | 13.76% |
Cash from operations | -22.34M | -0.17% |
Cash from investing | -431.00K | 90.77% |
Cash from financing | 40.71M | 463.20% |
Net change in cash | 17.93M | 190.81% |
Free cash flow | -14.65M | 11.38% |
About
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
Founded
2007
Headquarters
Website
Employees
103